People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other, Other Technology, Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cision Ltd. | — | Other | Series D+ | $128.3M | $2.2B | 2019 |
| AtScale, Inc. | — | Other Technology | Series C | $79.8M | $372.9M | 2025 |
| TetraScience, Inc. | — | Biotech | Series C | $66.0M | $72.1M | 2021 |
| Tervela Inc | — | Other Technology | Series A | $5.2M | $142.9M | 2009 |
| Thoughtful, Inc. | — | Other Technology | Pre-Seed | $130K | $5.5M | 2010 |
| Flypaper, Inc. | — | Other Technology | Pre-Seed | $130K | $5.5M | 2013 |
Chris Lynch at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris Lynch on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Davoli | 1 | 22 |
| Deven Parekh | 1 | 21 |
| Michael Skok | 1 | 12 |
| Ryan Floyd | 1 | 8 |
| Mark Palmer | 1 | 6 |
| Patrick Grady | 1 | 5 |
| Michael Egan | 1 | 4 |
| Kevin P. Johnson | 1 | 3 |
| Chris Nevan | 1 | 3 |
| Eric Schnadig | 1 | 3 |
| Pete Perrone | 1 | 3 |
| Roseann Palmieri | 1 | 3 |
| Mark M. Anderson | 1 | 3 |
| STUART J. YARBROUGH | 1 | 2 |
| STEPHEN P. MASTER | 1 | 2 |
| STEVE SOLOMON | 1 | 2 |
| Peter Low | 1 | 2 |
| David P Zilberman | 1 | 2 |
| B. Douglas Morriss | 1 | 2 |
| Kevin Akeroyd | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.